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Natural Killer T (NKT) cells are lipid-reactive, CD1d-
restricted T lymphocytes important in infection,
cancer, and autoimmunity. In addition to foreign anti-
gens, NKT cells react with endogenous self lipids.
However, in the face of stimulating self antigen, it
remains unclear how overstimulation of NKT cells is
avoided. We hypothesized that constantly degraded
endogenous antigen only accumulates upon inhibi-
tion of a-galactosidase A (a-Gal-A) in lysosomes.
Here, we show that a-Gal-A deficiency caused
vigorous activation of NKT cells. Moreover, microbes
induced inhibition of a-Gal-A activity in antigen-
presenting cells. This temporary enzyme block de-
pended on Toll-like receptor (TLR) signaling and
ultimately triggered lysosomal lipid accumulation.
Thus, we present TLR-dependent negative regula-
tion of a-Gal-A as a mechanistic link between path-
ogen recognition and self lipid antigen induction for
NKT cells.
INTRODUCTION
Natural killer T (NKT) cells are a subpopulation of unconventional
T lymphocytes that express a restricted T cell receptor (TCR)
repertoire and several molecules characteristic for NK cells
(Bendelac et al., 2007; Kronenberg, 2005). Following activation,
NKT cells respond by a rapid burst of cytokines secreting mainly
interferon-g (IFN-g) and interleukin-4 (IL-4), thus regulating the
quality of downstream immune responses (Bendelac et al.,
2007). Therefore, NKT cells play a role in various disease condi-
tions including infections (Tupin et al., 2007), cancer (Cui et al.,
1997; Dhodapkar, 2009), and autoimmunity (Shi and Van Kaer,
2006), such as diabetes (Hong et al., 2001; Sharif et al., 2001)
and multiple sclerosis (Miyamoto et al., 2001). NKT cells recog-
nize lipid antigens primarily belonging to the group of glycosphin-
golipids (GSLs) presented by nonclassical, major histocompati-216 Immunity 33, 216–228, August 27, 2010 ª2010 Elsevier Inc.bility class I (MHC-I)-like CD1d molecules mainly expressed on
dendritic cells (DCs) (Brigl andBrenner, 2004). The first described
and most potent NKT cell antigen is a-galactosylceramide
(aGalCer), initially isolated from the marine sponge Agelas
mauritianus (Kawano et al., 1997). Invariant NKT cells (iNKT) are
defined by their reactivity with aGalCer and, thus, are readily
detectable by binding to aGalCer-loaded CD1d-tetramers
(Matsuda et al., 2000; Benlagha et al., 2000). In the murine
system, iNKT cells are predominantly located in peripheral
tissues such as liver and spleen (Bendelac et al., 2007).
Upon infection, iNKT cells can be directly activated by patho-
gens that contain glycolipid antigens such asSphingomonas spp
(Mattner et al., 2005; Kinjo et al., 2005) and Borrelia burgdorferi
(Kinjo et al., 2006) that cause a multisystem inflammatory
disorder called Lyme disease. Moreover, Mycobacterium
tuberculosis contains a glycolipid antigen entity, phosphatidyli-
nositolmannoside (PIM), that is recognized by a subpopulation
of iNKT cells (Fischer et al., 2004).
In addition to exogenous antigens, iNKT cells react with self
lipids. Initial evidence for the existence of endogenous iNKT
cell antigens was provided by experiments demonstrating that
tail-truncated CD1d fails to select iNKT cells in the thymus
(Chiu et al., 2002). Since truncated CD1d is unable to traffic to
lysosomes, these results suggest that lysosomal lipids have to
be loaded onto CD1d for proper iNKT cell selection and activa-
tion (Chiu et al., 2002). Further, these endogenous lipids most
likely represent GSLs because iNKT cells are not able to recog-
nize CD1d-expressing antigen presenting cells (APCs) lacking
b-glucosylceramide (Stanic et al., 2003), which is the common
precursor molecule for the majority of GSLs. Moreover, analysis
of mice deficient for hexosaminidase B (Hex-B) reveals a lack of
iNKT cells (Zhou et al., 2004). Since Hex-B is the lysosomal
enzyme required for degradation of globotetraosylceramide
(Gb4) and isoGb4 (iGb4) into globotriaosylceramide (Gb3) and
isoGb3 (iGb3), respectively, it has been proposed that the
GSLs downstream of Hex-B could represent the endogenous
lipid ligands for iNKT cell selection and activation (Zhou et al.,
2004). Accordingly, Hex-B-deficient DCs fail to activate iNKT
cells in salmonella infection (Mattner et al., 2005). In contrast to
Gb3, iGb3 proves to be a potent antigen to stimulate iNKT cells
(Zhou et al., 2004; Mattner et al., 2005).
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known as to how uncontrolled activation of iNKT cells that poten-
tially leads to autoimmunity is prevented. We hypothesized that
under normal conditions, endogenous antigen such as iGb3 is
constantly degraded to lactosylceramide, which prevents intra-
lysosomal concentrations required for efficient CD1d loading
and productive iNKT cell induction. Only if lysosomal a-galacto-
sidase A (a-Gal-A), the rate-limiting enzyme of iGb3 turnover, is
blocked would endogenous antigen accumulate and reach the
threshold for subsequent iNKT cell activation.
The majority of pathogens potentially causing infection of the
host lack glycolipid antigens to directly stimulate iNKT cells.
However, facing this challenge, the host developed a pathway
to ensure proper iNKT cell activation upon infection. Accord-
ingly, pathogens lacking iNKT cell antigens induce the genera-
tion of self lipid antigens. This holds true for salmonella infection,
which potently induces iNKT cell activation, strictly dependent
on CD1d-presented self antigens and IL-12 secretion by
microbe-exposed DCs (Brigl et al., 2003). Moreover, bacterial
infections can promote the de novo synthesis of GSLs (De Libero
et al., 2005). Further, recent evidence demonstrates that
stimulation of DCs through Toll-like receptor (TLR)-9 using
CpG oligonucleotides elicits the production of charged GSLs
that mediate iNKT cell activation in the presence of type I inter-
ferons (Paget et al., 2007). However, how TLR engagement
affects lipid antigen generation remains elusive.
Here, we show that DCs deficient in a-Gal-A activity induced
vigorous iNKT cell activation in the absence of exogenous
antigen. Reconstitution of a-Gal-A-deficient (Gla/) DCs with
recombinant enzyme fully abrogated the iNKT cell response.
Moreover, lack of a-Gal-A promoted iNKT cell stimulation
in vivo. Endogenous iNKT cells in Gla/ hosts showed signs
of chronic exposure to self antigens. Beyond the model of
a-Gal-A deficiency, we demonstrate that bacterial infection
and microbial products induced inhibition of a-Gal-A activity in
wild-type DCs. This temporary enzyme block strictly depended
on TLR signaling through the adaptor protein MyD88 and ulti-
mately triggered lysosomal lipid accumulation. Taken together,
we propose that TLR-dependent inhibition of a-Gal-A in DCs
mechanistically couples pathogen recognition with generation
of lipid antigens for iNKT cell activation.
RESULTS
DCs Lacking a-Gal-A Activity Induce iNKT Cell
Responses
We hypothesized that catabolic GSL intermediates such as iGb3
are normally degraded by the action of a-Gal-A in the lysosome,
thus preventing antigen presentation to iNKT cells. Following this
idea, endogenous antigen has to be rescued fromdegradation to
be sufficiently abundant for iNKT cell activation. To this end, we
generated bone marrow-derived DCs from Gla/ and wild-type
(WT) mice and cocultured themwith iNKT cells isolated from liver
and thymus of Va14-transgenic animals. As positive control, we
pulsed both antigen-presenting cells (APCs) with aGalCer and
added a blocking antibody against CD1d in parallel in order
to assess CD1d restriction of T cell activation. Two days after
incubation, we measured 3H-thymidine incorporation into the
DNA of expanding cells detected by counts per minute (cpm).In the absence of exogenous antigen, Gla/ DCs induced
vigorous proliferation of liver as well as thymic iNKT cells in con-
trast to WT DCs (Figure 1A and Figure S1A available online).
The iNKT cell response was fully abrogated in the presence of
blocking antibody, indicating that self antigen was presented
through CD1d. DCs deficient for a-Gal-A normally activated
iNKT cells by aGalCer, excluding any impairment of the lipid
antigen presentation pathway (Figure 1A). Moreover, Gla/
DCs efficiently presented ovalbumin to conventional T cells,
showing normal peptide antigen presentation in APCs lacking
a-Gal-A (Figure S1B).
To demonstrate effector functions of iNKT cells, we cocultured
Gla/ and WT DCs with liver iNKT cells and measured cytokine
secretion of IFN-g and IL-4 by ELISA. Without addition of
exogenous antigen, a-Gal-A-deficient DCs potently elicited
IFN-g and IL-4 secretion by iNKT cells in sharp contrast to
untreated WT DCs (Figure 1B). Importantly, cytokine secretion
by activated iNKT cells was fully abrogated when Gla/ DCs
additionally lacking CD1d (Gla/Cd1d1/) were used for
T cell stimulation (Figure 1B). In parallel, we treated WT DCs
with the specific a-Gal-A inhibitor deoxygalactonojirimycin
(DGJ) (Fan et al., 1999). Blocking of a-Gal-A enzymatic activity
in WT DCs induced CD1d-restricted cytokine secretion by
activated liver iNKT cells (Figure 1B). Finally, we reconstituted
a-Gal-A-deficient APCs with recombinant enzyme prior to func-
tional T cell assays and showed that iNKT cell activation was
completely abolished (Figure 1B). To substantiate our findings
with primary iNKT cells, we performed analogous experiments
using autoreactive NKT cell hybridoma. Both a-Gal-A-deficient
DCs and WT DCs treated with DGJ strongly stimulated the
invariant NKT cell hybridoma DN32.D3 in contrast to the nonin-
variant NKT cell hybridoma TCB11 (Figure 1C). Consistently,
enzyme reconstitution or coculture with Gla/Cd1d1/ DCs
abolished DN32.D3 stimulation (Figure 1C). Notably, b-galacto-
sidase-deficient DCs failed to increase the autoreactive
response of DN32.D3 cells, underlining the specific function of
a-Gal-A in generation of endogenous antigens for iNKT cells
(Figure 1C). As control, Gla/ APCs normally stimulated
invariant NKT cell hybridoma by exogenous lipid antigens
(Figure S1C).
Next, we aimed at further defining the entity of the endogenous
antigens that accumulate in a-Gal-A deficiency. For this
purpose, we used the isolectin B4 (IB4), which specifically binds
to digalactose residues in a1,3-glycosidic linkage as it is present
in iGb3, and thus blocks lipid recognition by T cells. In this
context, we pretreated lipid-incubated WT and a-Gal-A-defi-
cient DCs as well as unpulsed APCs with IB4, prior to coculture
with the invariant NKT cell hybridoma DN32.D3. IB4 incubation
had no effect on the presentation of aGalCer by WT or Gla/
DCs (Figure 1D). However, the T cell response to iGb3-pulsed
DCs was inhibited in a dose-dependent manner and reduced
by 70%–80% at high IB4 concentrations. Similarly, IB4-medi-
ated blocking fully abrogated iNKT hybridoma responses
induced by Gla/ APCs (Figure 1D). In addition, IB4-mediated
block of self antigen recognition drastically reduced the a-Gal-
A-dependent activation of primary liver iNKT cells (Figure 1D).
In order to define the class of lipid antigen involved in a-Gal-A-
mediated iNKT cell induction, we incubated WT and Gla/
DCs for different periods of time with N-butyl-DGJ (NB-DGJ)Immunity 33, 216–228, August 27, 2010 ª2010 Elsevier Inc. 217
Figure 1. DCs Lacking a-Gal-A Activity Induce iNKT Cell Responses
(A) DCs from wild-type (WT) or Gla/ mice were pulsed with aGalCer (100 ng/ml) for 16 hr, or were left untreated, before coculture with liver iNKT cells from
Va14-Ja18 transgenic mice. Additionally, DCs were treated with CD1d-blocking antibody (20 mg/ml) or isotype control (iso, 20 mg/ml). Two days after stimulation,
antigen-specific proliferation was determined by [3H]-thymidine incorporation as depicted by counts per minute (CPM).
(B) DCs fromWT orGla/mice were treated with DGJ (1 mM), or human recombinant a-Gal-A (Replagal, 20 mg/ml), or were left untreated. In parallel, DCs were
pulsed with iGb3 (1 mg/ml) for 16 hr. After washing, DCs were cocultured with liver iNKT cells. Moreover, DCs additionally lacking CD1d expression (Cd1d1/)
were used as APCs. Three days after stimulation, cytokines released in the culture supernatants were determined by ELISA.
(C) DCs fromWT,Gla/,Gla/Cd1d1/, or b-Gal-deficient (Glb1/) mice were cocultured with the invariant NKT cell hybridoma DN32.D3 or the noninvariant
TCB11. Additionally, WT APCs were preincubated with 1 mM DGJ, and Gla/ DCs were reconstituted with 10 or 20 mg/ml recombinant a-Gal-A. One day after
coculture, IL-2 secretion of hybridoma cells was measured by ELISA. (A–C) Graphs show mean ± SD of triplicate cultures.
(D) IB4-mediated blocking of endogenous antigens abrogates iNKT cell activation by a-Gal-A-deficient APCs.Gla/ andWT DCs were pulsed for 6 hr with iGb3
(400 ng/ml), aGalCer (100 ng/ml), or were left unpulsed. In addition, DCs were preincubated with 0.5–5 mg/ml IB4 for 2 hr or were left untreated. Subsequently,
APCs were cocultured with the invariant NKT cell hybridoma DN32.D3 for 1 day, prior to measurement of IL-2 by ELISA. Depicted is the percentage of the
remaining IL-2 response of iNKT cells upon IB4 treatment compared to untreated DCs (Unpulsed, 200 pg/ml; iGb3, 277 pg/ml and 638 pg/ml; aGalCer,
2866 pg/ml and 3824 pg/ml, for WT or Gla/ DCs, respectively). In the right panel, Gla/ DCs were preincubated with 0.5–2 mg/ml IB4 or were left untreated.
Subsequently, APCs were cocultured with primary liver iNKT cells, and secretion of IFN-g and IL-4 was measured by ELISA 2 days after stimulation. Depicted is
the percentage of the remaining cytokine response of liver iNKT cells upon IB4 treatment compared to untreated DCs (758 pg/ml for IFN-g and 304 pg/ml for IL-4)
(E) WT and Gla/ DCs were incubated with 100 mg/ml NB-DGJ for the indicated period of time or were left untreated. Subsequently, APCs were cocultured
with the invariant NKT cell hybridoma DN32.D3, and IL-2 secretion was measured by ELISA 1 day after stimulation. Depicted is the percentage of the remaining
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a-Gal-A Regulates NKT Cell Activation by Selfthat inhibits b-glucosylceramide-synthase, which produces the
main precursor for the majority of GSLs. Figure 1E shows the
reduction of iNKT cell-derived IL-2 upon DC treatment with
NB-DGJ compared to untreated DCs. Although short-term
treatment of Gla/ DCs with NB-DGJ had virtually no effect
on iNKT cell stimulation, inhibitor incubation for up to 5 days
reduced activation of iNKT cells to 50% (Figure 1E). At the
concentrations tested, NB-DGJ was not toxic and did not affect
the phenotype of DCs (Figure S2A). As further controls, we
excluded that the capacity of a-Gal-A-deficient APCs to strongly
activate iNKT cells was due to increased CD1d expression,
different APC phenotype (Figures S2B and S2C), or differential
localization of complexes of self lipids and CD1d to lipid rafts
(Figure S3).
Taken together, we demonstrate in vitro that lack of a-Gal-A
enzymatic activity promotes the production of self antigens to
activate iNKT cells.a-Gal-A Deficiency Promotes Activation of iNKT Cells
In Vivo
Next, we analyzed the impact of lacking a-Gal-A on iNKT cell
activation in vivo. WT recipient mice received 1 3 106 WT,
Gla/, or Gla/Cd1d1/ DCs intravenously. As a positive
control, we administered WT DCs pulsed with iGb3. We deter-
mined activation of liver iNKT cells measuring TCR downmodu-
lation by flow cytometry 18 hr after DC transfer. Moreover, we
measured upregulation of the activation marker molecules
CD69 and CD25 on the surface of iNKT cells. Following stimula-
tion with Gla/ DCs, the frequency of aGalCer-loaded CD1d-
tetramer+ cells among liver lymphocytes was reduced by half
(12%) when compared to unpulsed WT DCs (23%) and
Gla/Cd1d1/ DCs (24%) (Figure 2A). Since reduced
frequencies of CD1d-tetramer+ iNKT cells indicate TCR down-
modulation upon activation, a-Gal-A-deficient DCs induced
CD1d-dependent stimulation of iNKT cells in vivo. The bar chart
in Figure 2A shows the significant differences in liver iNKT cell
percentages in recipient mice stimulated with the different types
of DCs when compared to PBS-treated control animals. These
findings were corroborated by increased expression of CD69
and CD25 molecules by liver iNKT cells subsequent to stimula-
tion with Gla/ in contrast to Gla/Cd1d1/ DCs (Figure 2B).
Further, we examined the expansion of transferred iNKT cells
in an a-Gal-A-deficient host environment. For this purpose,
CFSE-labeled thymocytes isolated from Va14-transgenic mice
were transferred intravenously into sublethally irradiated Gla/,
Gla/ Cd1d1/, WT, or Cd1d1/ recipient mice. Nine days
after adoptive T cell transfer, lymphocytes from livers of recipient
mice were stained with CD1d-tetramers to identify iNKT cells,
and CFSE dilution profiles reflecting iNKT cell proliferation
were determined by flow cytometry. Transferred iNKT cells in
WT, Cd1d1/, and Gla/ Cd1d1/ recipients showed a clas-
sical homeostatic proliferation pattern with the majority of cells
undergoing two to three rounds of cell division (Matsuda et al.,
2002) (Figure 2C). In sharp contrast, the proliferation profile in
Gla/ mice showed that the majority of iNKT cells underwentIL-2 response of iNKT cells upon NB-DGJ treatment compared to untreated DCs
triplicate cultures. (A–E) Results depicted are representative of at least three inde
analyzed by Student’s t test. NS, not significant.four to six rounds of division. This was also reflected by the
mean fluorescence intensity (MFI) of CFSE+ iNKT cells in Gla/
mice, which was reduced by half compared to Gla/Cd1d1/
recipients, indicating an increased expansion of iNKT cells in
a-Gal-A deficiency (Figure 2C). In parallel, we determined the
proliferation of cotransferred conventional T cells in Gla/,
Gla/Cd1d1/, WT, or Cd1d1/ recipient mice. Accordingly,
CFSE dilution of TCRb+ CD1d-tetramer T cells was not
enhanced in Gla/ recipients when compared to control mice
(Figure 2C). In addition, we tested the expansion of transferred
iNKT cells in a-Gal-A-deficient and WT hosts upon exogenous
antigenic stimulation with aGalCer. In contrast to the abundance
of conventional T cells, the frequencies of transferred iNKT cells
in liver and spleen were drastically increased in Gla/ mice
when compared to WT recipients (Figure S4).
Taken together, our findings demonstrate that lack of a-Gal-A
facilitates iNKT cell activation in vivo.Peripheral iNKT Cells Show Signs of Chronic Exposure
to Self Antigens in Gla/ Mice
Subsequently, we investigated the endogenous iNKT cell popu-
lation of a-Gal-A-deficient mice with regard to signs of overstim-
ulation possibly because of chronic antigen exposure. After
staining thymus, spleen, and liver of Gla/ mice using CD1d-
tetramers, flow cytometry revealed that iNKT cell numbers
were reduced mainly in peripheral tissues like liver and spleen
(Figure 3A). Loss of peripheral iNKT cells could be either because
of impaired thymic selection and subsequent decreased output
to the periphery, or might be the consequence of increased
activation-induced cell death due to overstimulation in peripheral
tissues. In order to address the first option, we provided Gla/
and WT mice with bromodeoxyuridine (BrdU) in the drinking
water for 5 days. Subsequently, CD1d-tetramer+ thymocytes
were stained for BrdU incorporation, reflecting their endogenous
expansion. In addition, thymic iNKT cells were stained for
CD44 and NK1.1 to determine their maturation stages. Flow-cy-
tometric analysis revealed that the expansion of immature,
semimature, and mature thymic iNKT cells in Gla/ mice was
comparable to WT animals as indicated by the percentage of
BrdU+ cells (Figure 3B). Additionally, we analyzed the prolifera-
tion of conventional lymphocytes in the thymus of Gla/ and
WT mice following BrdU administration. After 18 hr, thymic
lymphocytes were stained for heat stable antigen (HSA, CD24)
that is highly expressed on immature thymocytes and subse-
quently decreases upon T cell maturation. Figure 3B shows the
similar generation of CD1d-tetramer, NK1.1, HSA+ conven-
tional lymphocytes in a-Gal-A-deficient andWT thymi. In striking
contrast, the frequency of BrdU+ cells and, thus, the expansion
of liver and splenic iNKT cells compared to conventional
T lymphocytes and NK cells was markedly reduced in Gla/
mice (Figure 3C). Thus, homeostasis of iNKT cells is specifically
affected in the periphery of a-Gal-A-deficient mice.
To address the question of peripheral loss of iNKT cells due to
increased apoptosis, we intravenously injected a fluorogenic
substrate (Flivo) for poly-caspases, a group of enzymes(60 pg/ml for WT and 235 pg/ml for Gla/ DCs). Graphs show mean ± SEM of
pendent experiments with similar results. *p < 0.05; **p < 0.01; ***p < 0.001 as
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Figure 2. Absence of a-Gal-A Mediates
iNKT Cell Activation In Vivo
(A) a-Gal-A-deficient DCs activate iNKT cells
in vivo. Wild-type (WT) mice received intrave-
nously (i.v.) 1 3 106 WT DCs, pulsed with iGb3
(1 mg/ml) for 16 hr as indicated. Alternatively,
mice received 13 106 DCs generated fromGla/
or Gla/Cd1d1/ mice. As controls, recipient
animals received PBS or untreated WT DCs. After
18 hr, liver mononuclear cells were analyzed by
flow cytometry. The percentages of iNKT cells
defined as aGalCer-loaded CD1d-tetramer+
TCRb+ cells among B220 lymphocytes are de-
picted in the dot plots. The right panel shows the
differences in liver iNKT cell percentages in recip-
ient mice stimulated with the different types of
DCs when compared to PBS-treated control
animals. For the bar chart, the data from five inde-
pendent experiments were pooled, including three
mice per group. *p < 0.05; **p < 0.01; ***p < 0.001
as analyzed by one-way ANOVA with variance
comparison between all groups followed by a
Bonferroni post-test.
(B) Surface expression of CD25 and CD69 by iNKT
cells was analyzed upon transfer of Gla/, Gla/
Cd1d1/, or iGb3-pulsed WT DCs, as described
in (A).
(C) Deficiency of a-Gal-A promotes iNKT cell
expansion in vivo. Thymocytes from Va14-Ja18
transgenic mice were subjected to CD8+ T cell
depletion, labeled with CFSE, and injected intra-
venously (i.v.) into sublethally irradiated WT,
Cd1d1/, Gla/, or Gla/Cd1d1/ mice. Nine
days after adoptive transfer, iNKT cells prepared
from livers of recipient mice were identified by
flow cytometric staining with anti-TCRb and
CD1d-tetramers as shown in the dot plots. In
parallel, cotransferred conventional T cells were
detected as TCRb+, CD1d-tetramer liver lympho-
cytes. Histograms of the left panel demonstrate
the proliferation profiles of CFSE-labeled trans-
ferred iNKT cells, including their mean fluores-
cence intensity (MFI). The right panel depicts
CFSE dilution of conventional T cells as controls.
(B and C) Shown is one representative experiment
of three performed with similar results.
Immunity
a-Gal-A Regulates NKT Cell Activation by Selfactivated upon activation-induced cell death, intoGla/ andWT
mice. After 45 min, iNKT cells from liver and thymus were
detected by CD1d-tetramers, and Flivo fluorescence was
measured by flow cytometry. Liver iNKT cells in Gla/ mice
exhibited an increased frequency (up to 20%) of apoptotic cells
compared to WT animals (Figure 4A). Moreover, conventional
T cells and NK cells did not exhibit Flivo fluorescence in liver
and spleen of Gla/ mice (data not shown), indicating that
increased apoptosis was specific for iNKT cells in a-Gal-A
deficiency.
Of note, persistent antigenic stimulation of iNKT cells leads to
upregulation of inhibitory receptors of the Ly49 family (Hayakawa
et al., 2004). Therefore, we investigated the expression of Ly49
molecules on the surface of iNKT cells in a-Gal-A-deficient
mice and found iNKT cells expressing Ly49C/I were markedly220 Immunity 33, 216–228, August 27, 2010 ª2010 Elsevier Inc.enriched in liver and spleen when compared to WT mice
(Figure 4B). Finally, we examined whether iNKT cells in a-Gal-A
deficiency display a state of functional tolerance to antigenic
stimulation. For this purpose, we challenged Gla/ mice
compared to WT animals with 2 mg aGalCer and, 3 hr later,
analyzed intracellular IFN-g production of liver iNKT cells using
flow cytometry. The intracellular IFN-g response of iNKT cells
to aGalCer in Gla/ mice was impaired compared to that in
WT animals (Figure 4C). The serum concentrations of IFN-g,
measured 16 hr after aGalCer challenge, were equally dimin-
ished in Gla/ mice (Figure 4D). To conclude, our findings on
increased apoptosis, augmented L49C/I expression, and
functional unresponsiveness suggest that iNKT cells are prone
to overstimulation and tolerance induction in a-Gal-A deficiency
indicative for chronic antigen exposure.
Figure 3. Homeostasis of iNKT Cells Is Impaired in the Periphery of a-Gal-A-Deficient Hosts
(A) Specific loss of peripheral iNKT cells is a hallmark of Gla/mice. Dot plots show percentages of aGalCer-loaded CD1d-tetramer+ CD44+ iNKT cells among
liver mononuclear cells, splenocytes, and thymocytes from WT or Gla/ mice measured by FACS. The bar charts demonstrate the percentages or absolute
numbers of iNKT cells in liver, spleen, or thymus of a-Gal-A-deficient compared to WT mice.
(B) WT and Gla/ mice received BrdU (0.8 mg/ml) in the drinking water. Five days later, mice were sacrificed and BrdU incorporation by immature (CD44
NK1.1), semimature (CD44+ NK1.1), and mature (CD44+ NK1.1+) thymic iNKT cells was analyzed after intracellular staining with a BrdU antibody. iNKT cells
were identified as aGalCer-loaded CD1d-tetramer+ TCRb+ cells. Additionally, the generation of conventional T cells was analyzed in a-Gal-A-deficient and WT
thymi by detection of CD1d-tetramer, NK1.1, HSA+ lymphocytes. Depicted are the percentages of BrdU-incorporating cells.
(C) Following the same approach as described in (B), liver and splenic iNKT cells in Gla/ and WT mice were analyzed for BrdU incorporation, including
the detection of conventional T cells and NK cells as controls. (A–C) Results are representative of at least three independent experiments with similar results.
Error bars depicted in graphs represent mean values ± SD. *p < 0.05; **p < 0.01; ***p < 0.001 as analyzed by Student’s t test. NS, not significant.
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Figure 4. Peripheral iNKT Cells Show Signs of Chronic Exposure to Self Antigens in Gla/ Mice
(A) WT andGla/mice received i.v. a fluorescent poly-caspase substrate (Flivo). After 45min,micewere sacrificed, and substrate fluorescence wasmeasured in
aGalCer-loaded CD1d-tetramer+ TCRb+ iNKT cells.
(B) Dot plots show the percentages of liver, spleen, and thymus iNKT cells expressing surface Ly49C/I in WT andGla/mice. iNKT cells were identified as in (A).
(C) Peripheral iNKT cells inGla/mice are tolerant. WT andGla/mice received i.v. aGalCer in PBS containing 0.5% polysorbate 20 or PBS/0.5% polysorbate
20 alone (vehicle). After 3 hr, mice were sacrificed and liver mononuclear cells were isolated and stained with aGalCer-loaded CD1d-tetramers and TCRbmAb.
Cells were fixed and permeabilized prior to intracellular IFN-g staining analyzed by flow cytometry. (B and C) Numbers in dot plots represent percentages of
Ly49C/I+ or IFN-g+ iNKT cells in the respective quadrants.
(D) Serum concentrations of IFN-g in WT andGla/mice were determined by ELISA 16 hr following i.p. injection of aGalCer in vehicle or vehicle alone. Error bars
depicted in graphs represent mean values ± SEM (A–D). Results are representative of at least three independent experiments with similar results. At least three
mice were used per group.
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Responses by iNKT Cells
In infection, DCs recognize microbes by binding of pathogen-
associated molecular patterns (PAMPs) through TLRs and
consequently produce self lipid antigens for iNKT cell activation
(Brigl et al., 2003; Paget et al., 2007; Salio et al., 2007). There-
fore, we investigated the impact of a-Gal-A deficiency on the
antimicrobial iNKT cell response. For this purpose, we incubated
Gla/ compared to WT DCs with Listeria monocytogenes, or
the TLR ligands LPS and CpG oligodeoxynucleotides (ODN),
and subsequently measured cytokine secretion by iNKT cells.
Infection and treatment with PAMPs mainly triggered IFN-g
production by iNKT cells when compared to the amount of
secreted IL-4. Importantly, the magnitude of IFN-g secretion
induced by WT DCs incubated with bacteria or PAMPs was
similar to the amount triggered by untreated Gla/ DCs
(Figure 5). Moreover, the IFN-g response by activated iNKT cells
was drastically amplified when a-Gal-A-deficient DCs were used
as APCs upon bacteria or PAMP treatment (Figure 5). This
increase in cytokine response was fully abrogated when Gla/222 Immunity 33, 216–228, August 27, 2010 ª2010 Elsevier Inc.Cd1d1/ DCs were used for iNKT cell stimulation, reemphasiz-
ing that induced self antigens were presented through CD1d in
a-Gal-A-lacking APCs. Of note, iNKT cell activation by patho-
gens or their microbial products strictly depended on TLR
signaling because DCs deficient for the TLR adaptor molecule
MyD88 failed to stimulate iNKT cells (Figure 5). The augmented
IFN-g secretion by iNKT cells upon stimulation with Gla/ DCs
treated with PAMPs was mediated by DC-derived IL-12
because addition of IL-12 neutralizing antibody to cocultures
reduced the cytokine concentration to the amount of untreated
Gla/ DCs (Figure S5A). However, a-Gal-A-deficient DCs did
not produce higher baseline concentrations of IL-12p70 when
compared to WT DCs (Figure S5B). Finally, preincubation of
a-Gal-A-deficient DCs with the inhibitor of b-glucosylcera-
mide-synthase, NB-DGJ, did not alter the enhancement of the
antimicrobial iNKT cell response (Figure S5C). This suggests
that catabolic rather than newly synthesized GSLs are respon-
sible for iNKT cell activation by Gla/ APCs. Taken together,
we show that DCs lacking a-Gal-A amplify the antimicrobial
response of iNKT cells.
Figure 5. DCs Lacking a-Gal-A Amplify
Antimicrobial Responses by iNKT Cells
DCs from WT, Myd88/, Gla/, and Gla/
Cd1d1/ mice were incubated for 16 hr with
L. monocytogenes, LPS (1 mg/ml), CpG ODN
(2 mg/ml), or were left untreated, prior to coculture
with liver iNKT cells. After 72 hr, IFN-g release into
the culture supernatants was quantified by ELISA.
Results are representative of at least three inde-
pendent experiments with similar results. Error
bars depicted in column graphs represent mean
values ± SEM of triplicate cultures. *p < 0.05;
**p < 0.01; ***p < 0.001 as analyzed by Student’s
t test. NS, not significant.
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a-Gal-A Regulates NKT Cell Activation by SelfMicrobes Inhibit a-Gal-A Activity in APCs Through
MyD88-Dependent TLR Signaling
Since (1) TLR engagement induces iNKT cell activation by self
antigens and (2) lack of a-Gal-A induces iNKT cell activation by
self antigens, we hypothesized that TLR engagement is equiva-
lent to an a-Gal-A block. Beyond the use of a-Gal-A-deficient
mice as a model, we considered TLR-mediated inhibition of
a-Gal-A activity as a physiological mechanism. To test this
hypothesis, we incubated WT and MyD88-deficient DCs with
L. monocytogenes, the TLR-4-ligand LPS, or the TLR-3-ligand
polyI:C, a synthetic double-stranded RNA. After 2–20 hr, DCs
were disrupted for subsequent measurement of a-Gal-A activity
using the specific fluorogenic substrate 4-methylumbelliferyl-
a-D-galactopyranoside. Exposure to listeriae or LPS resulted in
a 50% reduction of a-Gal-A enzyme activity compared to
untreatedWTDCs (Figure 6). In contrast, stimulation with polyI:C
had no effect on a-Gal-A activity. Of note, enzymatic activity
upon stimulation with LPS recovered to baseline levels after
20 hr incubation, indicating temporary inhibition of a-Gal-A byFigure 6. TLR Stimulation Mediated through MyD88 Inhibits a-Gal-A A
WT and Myd88/ DCs were incubated with L. monocytogenes (MOI 5), expo
After extensive washing, DC pellets were disrupted, and a-Gal-A activity was m
of a-Gal-A is indicated as percentage of remaining enzyme activity as compared
experiments with similar results.PAMPs. Importantly, enzyme block by bacteria and PAMPs
was abolished in the absence of the TLR-adaptor molecule
MyD88 (Figure 6). The absolute values of a-Gal-A activity were
similar between untreated WT and Myd88/ DCs or decreased
upon treatment with DGJ, whereas no activity was detected in
a-Gal-A-deficient DCs (Table S1). Further, we determined the
transcriptional regulation of a-Gal-A and other GSL-degrading
or biosynthetic enzymes by quantitative real-time RT-PCR.
Expression of a-Gal-A was strongly upregulated in DCs treated
with LPS (Figure S6). Thus, reduction of a-Gal-A enzymatic
activity upon PAMP treatment of DCs was not because of
transcriptional downregulation.
Taken together, we demonstrate that TLR signaling leads to
temporary inhibition of a-Gal-A activity in DCs.
a-Gal-A Is a Central Regulator of TLR-Induced
Lysosomal GSL Accumulation
Inhibition or lack of a-Gal-A enzyme activity leads to intralysoso-
mal accumulation of lipids upstream of a-Gal-A in the GSLctivity in DCs
sed to LPS (1 mg/ml), or polyI:C (10 mg/ml) for the indicated period of time.
easured in lysates using a fluorogenic substrate specific for a-Gal-A. Activity
to WT, untreated DCs. Results are representative of at least five independent
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Figure 7. a-Gal-A Is a Central Regulator of TLR-Induced Lysosomal GSL Accumulation
(A) DCs from WT and Gla/ mice were incubated with Alexa 488-coupled STxB (5 mg/ml) for 30 min at 37C. After extensive washing, DCs were stained with
CD11c mAb, washed, and analyzed by FACS. Numbers in dot plots represent percentages of STxB+ DCs in the respective quadrants.
(B) WT andMyD88-deficient DCs were incubated with Alexa 488-coupled STxB (5 mg/ml) for 30 min, before LPS (1 mg/ml), polyI:C (10 mg/ml), CpGODN (2 mg/ml),
or beads were added for 12 hr. In parallel, DCs were treated with bafilomycin A1 (50 nM) for 1 hr prior to incubation with STxB. After extensive washing, DCs
were analyzed by flow cytometry. Histograms represent STxB fluorescence measured in untreated compared to treated CD11c+ DCs. (A and B) Shown is
one representative experiment out of three performed with similar results.
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a-Gal-A Regulates NKT Cell Activation by Selfdegradation pathway. One of these GSLs is Gb3, which also
functions as a receptor for Shiga toxin subunit B (STxB) in B cells
and DCs (Pina et al., 2007). Since iGb3 detection requires
complex techniques such as ion trap mass spectrometry
(Li et al., 2008; Li et al., 2009), we used detection of the a-Gal-
A substrate Gb3 as a reporter system for lipid accumulation
upon a-Gal-A inhibition. To this end, we employed fluoro-
chrome-coupled STxB for staining Gb3 by flow cytometry.
Indeed, due to accumulation of a-Gal-A-dependent lipid
substrates, STxB staining for Gb3 was drastically increased in
a-Gal-A-deficient compared to WT DCs (Figure 7A).
Next, we incubated WT and MyD88-deficient DCs with fluoro-
chrome-conjugated STxB and subsequently stimulated the cells
with PAMPs such as LPS, CpG oligonucleotides, and polyI:C, or
left DCs untreated. After 12 hr of incubation, cells were analyzed
by flow cytometry. LPS and CpG oligonucleotides increased
STxB staining of DCs compared to untreated cells, indicating
GSL accumulation (Figure 7B). Most importantly, this increase
in STxB staining was completely abrogated in MyD88-deficient
DCs, which is consistent with the TLR-dependent inhibition of
a-Gal-A activity to induce lipid accumulation. On the other
hand, polyI:C did not induce lipid accumulation in DCs as indi-224 Immunity 33, 216–228, August 27, 2010 ª2010 Elsevier Inc.cated by lack of increased STxB staining (Figure 7B), which is
in line with absent a-Gal-A inhibition upon stimulation with
polyI:C. Moreover, we excluded nonspecific effects on GSL
induction mediated by triggering of the endocytotic machinery
because latex beads applied to DCs did not affect STxB staining
(Figure 7B). Finally, we showed that lipid accumulation critically
depended on lysosome function because blocking lysosomal
acidification using bafilomycin fully abrogated STxB staining. In
conclusion, we demonstrate that a-Gal-A is a central regulator
of TLR-induced GSL accumulation.
DISCUSSION
Here we have demonstrated an essential function of the lyso-
somal enzyme a-Gal-A in the generation of self lipid antigens
for iNKT cell activation. UsingGla/mice as a model for consti-
tutive a-Gal-A deficiency, we have shown that DCs lacking the
lysosomal enzyme strongly activate iNKT cells a priori, without
additional sensitization or exogenously added antigen. Recon-
stituting a-Gal-A-deficient DCs with recombinant enzyme fully
abolished iNKT cell stimulation, demonstrating the pivotal role
of a-Gal-A in activation of iNKT cells by self antigen. Additionally,
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a-Gal-A Regulates NKT Cell Activation by Selfwe induced a-Gal-A deficiency in wild-type DCs using the
enzyme inhibitor DGJ, which resulted in productive antigen
presentation of CD1d-restricted endogenous lipids. These
experiments provide the proof of principle that a-Gal-A function
is central to controlling the threshold of endogenous antigen
availability. Further, the activation of an invariant in contrast to
noninvariant NKT cell hybridoma by Gla/ APCs corroborates
the notion that endogenous lysosomal lipids mediate iNKT cell
stimulation in a-Gal-A deficiency. Notably, b-Gal-deficient DCs
did not amplify the induction of iNKT cells, indicating that
nonspecific lysosomal lipid storage was not responsible for the
a-Gal-A-mediated mechanism of iNKT cell activation. Moreover,
the IB4-mediated abrogation of iNKT cell stimulation by a-Gal-A-
deficient DCs strongly suggests that endogenous GSLs that
bear a terminal Gal(a1,3)Gal disaccharide residue such as iGb3
are the respective antigens accumulating in a-Gal-A deficiency.
Lack of a-Gal-A also facilitated iNKT cell stimulation in vivo, as
shown by immunization of wild-type mice with a-Gal-A-deficient
DCs, as well as adoptive transfer of thymic iNKT cells upon
Gla/ recipients. Of note, genetic combination of a-Gal-A defi-
ciency and lack of CD1d totally abrogated iNKT cell activation,
indicating a-Gal-A-dependent presentation of CD1d-restricted
self antigen.
In 1967, the enzyme mediating the degradation of Gb3 to
lactosylceramide was described as ceramidetrihexosidase, later
called a-galactosidase A, and its enzymatic defect has been
shown to cause Fabry disease (Brady et al., 1967). In patients,
this lysosomal storage disorder is characterized by the accumu-
lation of Gb3 (Desnick and Schuchman, 2002). Since endothelial
cells are mainly affected by the stored lipids, thickened vessels
are themain reasons for Fabry symptoms, including skin lesions,
pain, and ischemia of heart, kidney, and brain (Beck, 2007).
Although the corresponding mouse model of Gla/ mice
accumulates a-Gal-A-dependent lipids, animals appear healthy
and do not show apparent clinical signs (Ohshima et al., 1997).
An early study investigating the processing of exogenous glyco-
lipids indicated a reduced frequency of splenic iNKT cells in
Gla/ mice (Prigozy et al., 2001). Consistently, we found
decreased numbers of iNKT cells in liver and spleen of a-Gal-
A-deficient animals. Reduced iNKT cell frequencies could be
because of either impaired thymic development or loss of
peripheral cells based on uncontrolled activation. Previous
reports suggested that lysosomal storage disorders affect
iNKT cell generation in the thymus (Gadola et al., 2006; Schu-
mann et al., 2007). Although this has been studied inmice lacking
b-hexosaminidase B or b-galactosidase, effects on thymic
selection were not demonstrated in Gla/ mice (Gadola et al.,
2006). Moreover, a recent study showed that single lysosomal
enzyme deficiencies do not interfere with thymic iNKT cell selec-
tion (Plati et al., 2009). Consistent with this, we observed normal
kinetics of iNKT cell development in the thymus of Gla/ mice.
Therefore, reduced iNKT cell numbers in a-Gal-A deficiency are
caused by peripheral loss putatively due to overstimulation by
accumulated self antigen. Accordingly, we found increased
activation-induced apoptosis of liver and splenic iNKT cells in
a-Gal-A-lacking mice. Further, iNKT cells in Gla/ hosts
displayed functional tolerance to antigenic challenge, as
reflected by markedly reduced cytokine responses to aGalCer
stimulation. Finally, peripheral iNKT cells in an a-Gal-A-deficientenvironment express Ly49C/I receptors at higher frequencies.
The family of inhibitory Ly49 molecules binds to MHC-I proteins
in order to silence autoreactive T cell responses (Dimasi et al.,
2004). Of note, chronic stimulation with glycolipid antigen upre-
gulates inhibitory Ly49 receptors on the surface of iNKT cells
(Hayakawa et al., 2004). Taken together, iNKT cells in peripheral
tissues of a-Gal-A-deficient hosts exhibit signs of chronic
antigen exposure.
In infection, DCs sense the presence of microbes by expres-
sion of a diverse set of TLRs binding to pathogen-associated
molecular patterns (PAMPs) (Janeway and Medzhitov, 2002;
Medzhitov, 2007; Takeda et al., 2003). TLR engagement by
DCs triggers the subsequent production of self lipid antigens
for induction of a predominant IFN-g response by iNKT cells
(Brigl et al., 2003; Paget et al., 2007; Salio et al., 2007). As
described for salmonella infection, activation of iNKT cells by
self antigens depends on IL-12 secretion by DCs (Brigl et al.,
2003). Upon infection or treatment with PAMPs, we demonstrate
that a-Gal-A-deficient DCs profoundly amplify antigen-specific
IFN-g production by iNKT cells. Whereas previous reports
demonstrated CD1d-independent, LPS-mediated iNKT cell
activation (Nagarajan and Kronenberg, 2007), we observed
CD1d-restriction of iNKT cell responses induced by infected or
PAMP-treated DCs.Moreover, the increase in cytokine secretion
strictly depended on DC-derived IL-12. It is conceivable that the
strong stimulatory capacity of Gla/ DCs induces enhanced
IFN-g secretion by iNKT cells, which in turn promotes IL-12
production by DCs in terms of a positive feed-back loop. Recent
studies suggest that TLR-activated DCs stimulate iNKT cells
through presentation of newly synthesized lipids (Paget et al.,
2007; Salio et al., 2007). However, inhibition of GSL neosynthesis
using the b-glucosylceramide synthase blocker NB-DGJ had
a minor effect on iNKT cell activation. Moreover, GSL synthesis
has been blocked during DC differentiation (Salio et al., 2007),
thus potentially reducing the overall GSL pool subsequently
available in lysosomes. In our experiments, stimulation of iNKT
cells by a-Gal-A-deficient DCs was not affected by short-term
treatment with NB-DGJ. Therefore, antigen presentation of lipids
relied rather on the accumulation of a-Gal-A-dependent cata-
bolic intermediates in lysosomes than on GSL neosynthesis.
The physiological mechanism we propose for the generation
of endogenous iNKT cell antigens involves the TLR-regulated
inhibition of a-Gal-A. Incubation of DCs with L. monocytogenes
or LPS rapidly induced a-Gal-A block. The reduction of enzy-
matic activity was not because of a-Gal-A downregulation,
because infection or PAMP treatment of DCs rather increased
a-Gal-A gene expression. Upon exposure to LPS, the enzyme
activity recovered 20 hr postincubation. Thus, TLR-regulated
enzyme inhibition turned out to represent a temporary a-Gal-A
block. Importantly, a-Gal-A inhibition critically depended on
the TLR adaptor molecule MyD88. The TLR-MyD88 axis has
been described to regulate phagosome maturation (Blander
and Medzhitov, 2006). It is thus tempting to speculate that
MyD88 could also influence late endosomal and lysosomal
function.
Furthermore, we investigated consequences of TLR signaling
and a-Gal-A inhibition on the lipid content of DCs. We used
fluorochrome-coupled STxB that specifically binds the a-Gal-A
substrate Gb3 as lipid reporter system for GSL accumulation inImmunity 33, 216–228, August 27, 2010 ª2010 Elsevier Inc. 225
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TLR-4 and TLR-9 ligands, LPS and CpG ODN, respectively,
induced GSL accumulation in a MyD88-restricted fashion. In
contrast, the TLR-3 ligand polyI:C did not influence lipid abun-
dance, which was consistent with its failure to mediate a-Gal-A
inhibition. In the light of well-established evidence that TLR
ligation leads to lipid antigen generation in DCs (Brigl et al.,
2003; Paget et al., 2007; Salio et al., 2007), we provide an
intertwining link between lysosomal enzyme inhibition and GSL
abundance.
The self lipid iGb3 is a potent antigen for iNKT cells (Zhou et al.,
2004; Mattner et al., 2005). However, its detection in tissues
proved to be delicate. Although previous studies were not able
to detect iGb3 by HPLC methods (Speak et al., 2007), more
recent work demonstrated its presence in thymus and DCs using
sensitive ion trap mass spectrometry (Li et al., 2008; Li et al.,
2009). However, generation of iGb3 synthase-deficient mice re-
vealed normal frequencies of iNKT cells in thymus and peripheral
tissues (Porubsky et al., 2007). Although an alternative pathway
of iGb3 synthesis can not be formally excluded, it is likely that
other endogenous ligands exist that mediate iNKT cell selection
in the thymus. Surprisingly, the studies investigating iGb3-syn-
thase-lacking mice did not include TLR stimulation of DCs to
measure self antigen-restricted iNKT cell activation (Porubsky
et al., 2007). Although it has been reported that myeloid-derived
suppressor cells (MDSCs) from iGb3-synthase-deficient mice
stimulate iNKT cells after TLR ligation (De Santo et al., 2008),
iGb3 could still represent the endogenous antigen that is induced
upon TLR engagement in DCs to activate iNKT cells in peripheral
tissues. Of note, it has been shown that iGb3 accumulates in
Gla/ mice (Li et al., 2009).
So far, iGb3 remains the placeholder of the veritable endog-
enous antigen for iNKT cells. Taking into account our data
derived from the model of a-Gal-A deficiency, the iNKT cell-
stimulating antigen has to be positioned upstream of a-Gal-A
and downstream of Hex-B. Thus, we consider it worthwhile
to analyze this biochemical layer for identification of the
endogenous iNKT cell antigen. Taken together, we propose
TLR-dependent block of a-Gal-A in DCs as mechanistic link




Ten to 18-week-old wild-type C57BL/6, Va14-Ja18 transgenic, Ja18-defi-
cient,Gla/,Gla/Cd1d1/,Cd1d1/, OT-1 TCR-transgenic, CD45.1 con-
genic, andMyd88/mice were bred under specific pathogen-free conditions.
Va14-Ja18 transgenic, Ja18-deficient, and Cd1d1/ breeders were kindly
provided by Dr. A. Bendelac, Chicago. b-Gal-deficient mice were provided
by Dr. A. d’Azzo, Memphis. All mice were on C57BL/6 background and
backcrossed for at least eight times. All procedures were approved by the
Institutional Animal Care and Use Committee.
Antibodies and Chemicals
Monoclonal antibodies against murine CD4, CD5, CD8, NK1.1, CD25, CD44,
Ly49C/I, TCR b chain, CD69, IFN-g, IL-4, CD1d, MHC-I, MHC-II, CD80,
CD86, and CD11cwere purchased fromBDBiosciences. ThemCD1d-specific
mAb K253 was a kind gift from Dr. S. Porcelli, New York. Neutralizing antibody
against murine IL-12 was purchased from R&D Systems. Chemically synthe-
sized aGalCer and isoglobotriaosylceramide (iGb3) were purchased from226 Immunity 33, 216–228, August 27, 2010 ª2010 Elsevier Inc.Enzo Life Sciences. Ultrapure LPS from Escherichia coli serotype 0111:B4,
polyI:C, and type B CpG ODN 1826 were from Cayla (Toulouse, France).
LPS from Salmonella enterica serotype abortus equi was from Sigma. 1-deox-
ygalactonojirimycin and N-butyl-deoxygalactonojirimycin were purchased
from Calbiochem. N-acetyl-N-galactosamine, 4-methylumbelliferyl-a-D-gal-
actopyranoside, MbCD, BrdU, and filipin III from Streptomyces filipinensis
were purchased from Sigma Aldrich. The isolectin B4 was purchased from
Vector Labs. Alexa Fluor 488-coupled recombinant Shiga Toxin B subunit
was kindly provided by Dr. L. Johannes, Paris, France.NKT Cell Hybridoma Assays
Bone marrow-derived DCs (5 3 104/well) were incubated with the murine
Va14+ iNKT cell hybridoma DN32.D3 (5 3 104/well) or with the murine Va8+
NKT cell hybridoma TCB11 (5 3 104/well) in 96-well round-bottom plates
and a final volume of 200 ml complete RPMI medium, prior to incubation at
37C and 5% CO2 for 20 hr. Where indicated, DCs were pulsed with different
concentrations of aGalCer or iGb3 for 6 or 16 hr before addition of NKT cell
hybridoma. Mouse IL-2 from coculture supernatants was measured by ELISA.
For iGb3 blocking experiments, DCswere incubated with IB4 at 37C for 2 hr at
the indicated concentrations and washed twice in medium before stimulation
of NKT cell hybridoma. To inhibit GSL synthesis, DCs were treated with
100 mg/ml NB-DGJ for the indicated period of time prior to iNKT cell assays.
NB-DGJ was also present during the stimulation experiments at 100 mg/ml.
To achieve cholesterol depletion, DCs were incubated with 10 mM MbCD in
complete medium for 15 min at 37C. After extensive washing, DCs were
cocultured with iNKT cell hybridoma.SUPPLEMENTAL INFORMATION
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